The University of Texas MD Anderson Cancer Center has signed a deal with Elekta (EKTA-B.ST) to acquire Elekta Infinity™ linear accelerators, brachytherapy afterloaders as well as software and service.
Bill Yaeger, Elekta’s Executive Vice President, Region North America, says: “As a world-renowned cancer center, MD Anderson has been a technology leader in managing the disease. In addition to being one of the first U.S. medical centers to acquire Elekta’s new Leksell Gamma Knife® Icon™ brain radiosurgery system, MD Anderson is also part of the consortium to develop the world’s first high-field MR-guided linear accelerator. We are proud that it has chosen us again in the expansion of its facilities in Texas. Both organizations share a commitment to quality and the best care possible for patients.”
The order, for four Infinity treatment systems, will also include Elekta’s high-resolution beam shaping solution, the Agility™ 160-leaf multi-leaf collimator.
The deal also includes four high-dose-rate (HDR) brachytherapy afterloaders and Oncentra® Brachy treatment planning; MOSAIQ® Oncology Information System (OIS); Active Breathing Coordinator™ units; as well as service for the hardware and software.
